Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Secukinumab in the treatment of moderate to severe hidradenitis suppurativa: Results of an open-label trial.
J Am Acad Dermatol. 2020 Jun;82(6):1524-1526. doi: 10.1016/j.jaad.2020.02.005. Epub 2020 Feb 7.
J Am Acad Dermatol. 2020.
PMID: 32044410
Clinical Trial.
No abstract available.
Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa.
Prussick L, Rothstein B, Joshipura D, Saraiya A, Turkowski Y, Abdat R, Alomran A, Zancanaro P, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D.
Prussick L, et al. Among authors: turkowski y.
Br J Dermatol. 2019 Sep;181(3):609-611. doi: 10.1111/bjd.17822. Epub 2019 May 12.
Br J Dermatol. 2019.
PMID: 30801662
Clinical Trial.
No abstract available.
Item in Clipboard
Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib.
Rothstein B, Joshipura D, Saraiya A, Abdat R, Ashkar H, Turkowski Y, Sheth V, Huang V, Au SC, Kachuk C, Dumont N, Gottlieb AB, Rosmarin D.
Rothstein B, et al. Among authors: turkowski y.
J Am Acad Dermatol. 2017 Jun;76(6):1054-1060.e1. doi: 10.1016/j.jaad.2017.02.049. Epub 2017 Apr 5.
J Am Acad Dermatol. 2017.
PMID: 28390737
Item in Clipboard
Importance of light in the treatment of vitiligo with JAK-inhibitors.
Joshipura D, Plotnikova N, Goldminz A, Deverapalli S, Turkowski Y, Gottlieb A, Rosmarin D.
Joshipura D, et al. Among authors: turkowski y.
J Dermatolog Treat. 2018 Feb;29(1):98-99. doi: 10.1080/09546634.2017.1339013. Epub 2017 Jun 29.
J Dermatolog Treat. 2018.
PMID: 28581823
No abstract available.
Item in Clipboard
Necrotizing Granulomas in a Patient With Psoriasis and Sarcoidosis After Adalimumab-Medication-Induced Reaction or Reactivation of Latent Disease?
Turkowski Y, Konnikov N, Mahalingam M.
Turkowski Y, et al.
Am J Dermatopathol. 2019 Sep;41(9):661-666. doi: 10.1097/DAD.0000000000001394.
Am J Dermatopathol. 2019.
PMID: 30839343
Item in Clipboard
Sulfasalazine-induced generalized vitiligo in a patient with dermatitis herpetiformis and celiac disease.
Turkowski Y, Konnikov N.
Turkowski Y, et al.
Dermatol Ther. 2019 Sep;32(5):e13007. doi: 10.1111/dth.13007. Epub 2019 Jul 8.
Dermatol Ther. 2019.
PMID: 31237078
Item in Clipboard
Pyoderma gangrenosum-like lesion secondary to methylenetetrahydrofolate reductase mutation: an unusual presentation of a rare disease.
Turkowski Y, Razvi S, Ahmed AR.
Turkowski Y, et al.
BMJ Case Rep. 2019 Apr 23;12(4):e228403. doi: 10.1136/bcr-2018-228403.
BMJ Case Rep. 2019.
PMID: 31015243
Free PMC article.
Item in Clipboard
Cite
Cite